Difference between revisions of "Rotation: Breast"
From MGH Learn Pathology
(→Diagnostic Entities) |
(→Diagnostic Entities) |
||
Line 29: | Line 29: | ||
# [[Breast:_DE:_Blunt_Duct_Adenosis|Blunt Duct Adenosis (BDA)]] | # [[Breast:_DE:_Blunt_Duct_Adenosis|Blunt Duct Adenosis (BDA)]] | ||
# [[Breast: DE: Ductal Carcinoma In Situ|Ductal Carcinoma In-situ (DCIS)]] | # [[Breast: DE: Ductal Carcinoma In Situ|Ductal Carcinoma In-situ (DCIS)]] | ||
− | # [[Fibroadenoma (FBA)]] | + | # [[Breast: DE: Fibroadenoma|Fibroadenoma (FBA)]] |
# [[Fibrocystic Changes (FCC)]] | # [[Fibrocystic Changes (FCC)]] | ||
# [[Hamartoma]] | # [[Hamartoma]] |
Revision as of 05:30, August 28, 2019
General
Sign-Out Tools
Coded Comments
Grading Chart: Ductal Carcinoma In-situ
Grading Chart: Invasive Carcinoma
Score Categories According to Field Diameter and Mitotic Count
Technical Grossing Manual
Didactics
Week 1
Weeks 2 & 3
Weeks 4 & 5
Diagnostic Entities
Weeks 2 & 3
- Blunt Duct Adenosis (BDA)
- Ductal Carcinoma In-situ (DCIS)
- Fibroadenoma (FBA)
- Fibrocystic Changes (FCC)
- Hamartoma
- Invasive Ductal Carcinoma (IDC)
- Invasive Lobular Carcinoma (ILC)
- Invasive Mucinous Carcinoma
- Lobular Carcinoma In-situ (LCIS)
- Papilloma
- Radial Scar
- Sclerosing Adenosis
- Tubular Carcinoma
- Usual Ductal Hyperplasia (UDH)
Weeks 4 & 5
- Adenoid Cystic Carcinoma
- Atypical Ductal Hyperplasia (ADH)
- Atypical Lobular Hyperplasia (ALH)
- Angiosarcoma
- Endocrine Carcinoma
- Fibromatosis
- Flat Epithelial Atypia (FEA)
- Medullary Carcinoma
- Metaplastic Carcinoma
- Mucocele-like Lesion
- Myofibroblastoma
- Myxoid Fibroadenoma
- Paget Disease
- Papillary Carcinoma
- Phyllodes Tumor
- Pleomorphic Lobular Carcinoma In-situ
- Pseudoangiomatous Stromal Hyperplasia (PASH)
- Radiation Changes
- Secretory Carcinoma